PCG
59
3
FRT
43
5
LEN
42
-4
ADBE
47
-9
BDX
60
6
QCOM
53
-2
NOV
40
-3
AON
32
-2
TDC
76
-10
HAL
39
-2
IFF
48
-2
LOW
50
-2
XEL
55
2
CCL
70
-2
ROK
54
2
DE
53
-3
CHRW
57
7
UNH
42
-4
BLK
60
-3
DLTR
48
-3
PCG
59
3
FRT
43
5
LEN
42
-4
ADBE
47
-9
BDX
60
6
QCOM
53
-2
NOV
40
-3
AON
32
-2
TDC
76
-10
HAL
39
-2
IFF
48
-2
LOW
50
-2
XEL
55
2
CCL
70
-2
ROK
54
2
DE
53
-3
CHRW
57
7
UNH
42
-4
BLK
60
-3
DLTR
48
-3
Financhill
Back

Cellectar Biosciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
23

CLRB
Cellectar Biosciences

Last Price:
0.25
Seasonality Move:
-1.67%
Sell
20

NBY
NovaBay Pharmaceuticals

Last Price:
0.56
Seasonality Move:
-8.54%
Sell
23
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $0.26. The Score for CLRB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.56. The Score for NBY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $0.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 5.91 Sell
Chaikin Money Flow: -6267615 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.11 - 2.03) Sell
Bollinger Bands (100): (1.63 - 2.29) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 37.85 Sell
Chaikin Money Flow: 45726 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.72) Sell
Bollinger Bands (100): (0.37 - 0.91) Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.11 Sell
20-day SMA: 1.43 Sell
50-day SMA: 1.82 Sell
200-day SMA: 2.6 Sell
8-day EMA: 0.97 Sell
20-day EMA: 1.34 Sell
50-day EMA: 1.69 Sell
200-day EMA: 2.29 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Sell
20-day SMA: 0.63 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2.02 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.61 Sell
50-day EMA: 0.67 Sell
200-day EMA: 4.96 Sell

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.81 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):